Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa Wilson, Hannah M. Harris, Shainnel O. Eans, et al.
Drug and Alcohol Dependence (2020) Vol. 216, pp. 108310-108310
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 686-693
Closed Access | Times Cited: 14
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 8
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F. DiBerto, Abdelfattah Faouzi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13873-13892
Open Access | Times Cited: 50
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa Wilson, Soumen Chakraborty, Shainnel O. Eans, et al.
Cellular and Molecular Neurobiology (2021) Vol. 41, Iss. 5, pp. 1131-1143
Open Access | Times Cited: 48
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Thiruventhan Karunakaran, Kok Zhuo Ngew, Ahmad Alif Danial Zailan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal EI Daibani, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 14, pp. 2661-2678
Open Access | Times Cited: 28
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Anna M. Gutridge, Soumen Chakraborty, Balázs R. Varga, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
Preston K. Manwill, Laura Flores‐Bocanegra, Manead Khin, et al.
Planta Medica (2022) Vol. 88, Iss. 09/10, pp. 838-857
Open Access | Times Cited: 19
Interactive Effects ofµ-Opioid and Adrenergic-α2Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
Samuel Obeng, Francisco León, Avi Patel, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 383, Iss. 3, pp. 182-198
Open Access | Times Cited: 19
Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception In Vivo
Yuchen Zhou, Steven Ramsey, Davide Provasi, et al.
Biochemistry (2020) Vol. 60, Iss. 18, pp. 1420-1429
Open Access | Times Cited: 28
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects
Oliver Grundmann, Katherine Hill, Everest Al Barzanji, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116779-116779
Closed Access | Times Cited: 9
Mitragynine Chemistry: Extraction, Synthesis, and Clinical Effects
Ferydoon Khamooshi, Ayobami Sunday Akinnawo, Samaneh Doraji-Bonjar, et al.
Chemistry Africa (2024) Vol. 7, Iss. 5, pp. 2907-2920
Closed Access | Times Cited: 3
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Cornel N. Stanciu, Saeed Ahmed, Samantha A. Gnanasegaram, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 509-528
Closed Access | Times Cited: 14
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Alessandro Vento, Simone De Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top